Panagiotis Dragonas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Panagiotis Dragonas has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Archontia Palaiologou
Department of Periodontics School of Dentistry University of Texas at San Antonio San Antonio Texas USA
2 shared publications - Gustavo Avila‐Ortiz
Department of Periodontics and Oral Medicine University of Michigan School of Dentistry Ann Arbor Michigan USA
2 shared publications Theodoros Katsaros
Univ Iowa, Coll Dent, Dept Periodont, Iowa City, IA 52242 USA
2 shared publicationsA. Palaiologou
DDS, MS. Department of Periodontics, School of Dentistry, University of Texas Health San Antonio, San Antonio, TX
1 shared publicationCharles Palin
Dental Service, Memorial Sloan Kettering Cancer Center, New York, NY
1 shared publicationGustavo Avila-Ortiz
Univ Iowa, Coll Dent, Dept Periodont, Iowa City, IA 52242 USA
1 shared publication
Latest Publications
- 1 September 2020
- Vol. 13 (3) , 213-232
Osteogenic capacity of the sinus membrane following maxillary sinus augmentation procedures: A systematic review
Purpose: The evidence pertaining to the contribution of the sinus membrane to new bone formation following maxillary sinus augmentation procedures is equivocal. The purpose of this study was to analyse the evidence currently available on the osteogenic capacity of the sinus membrane following maxillary sinus augmentation procedures, and the effect of local delivery of recombinant human bone morphogenic proteins (rhBMPs) on the bone-forming potential of the sinus membrane. Materials and methods: An electronic search was conducted using six different databases to identify controlled trials, prospective and retrospective cohort studies, case series and case reports, as well as preclinical (animal) studies reporting on new bone formation in close proximity with the sinus membrane after maxillary sinus augmentation procedures, assessed through histological and/or histomorphometrical evaluation, on the basis of pre-established eligibility criteria. Results: No clinical studies were identified. Twenty-six preclinical studies were included in the review. Nine of them supported the osteogenic potential of the sinus membrane, while eight reported no evidence of osteogenicity from the sinus membrane. The nine remaining studies reported on the local effect of rhBMPs. The majority of these nine studies reported enhanced new bone formation in the sinus membrane region. Conclusions: The sinus membrane contains pluripotent mesenchymal cells with the capacity to differentiate and participate in the process of new bone formation. However, the findings from the studies selected in this systematic review do not consistently support that the sinus membrane significantly contributes to new bone formation following maxillary sinus augmentation procedures.
- 1 September 2020
- Vol. 13 (3) , 213-232
Osteogenic capacity of the sinus membrane following maxillary sinus augmentation procedures: A systematic review
Purpose: The evidence pertaining to the contribution of the sinus membrane to new bone formation following maxillary sinus augmentation procedures is equivocal. The purpose of this study was to analyse the evidence currently available on the osteogenic capacity of the sinus membrane following maxillary sinus augmentation procedures, and the effect of local delivery of recombinant human bone morphogenic proteins (rhBMPs) on the bone-forming potential of the sinus membrane. Materials and methods: An electronic search was conducted using six different databases to identify controlled trials, prospective and retrospective cohort studies, case series and case reports, as well as preclinical (animal) studies reporting on new bone formation in close proximity with the sinus membrane after maxillary sinus augmentation procedures, assessed through histological and/or histomorphometrical evaluation, on the basis of pre-established eligibility criteria. Results: No clinical studies were identified. Twenty-six preclinical studies were included in the review. Nine of them supported the osteogenic potential of the sinus membrane, while eight reported no evidence of osteogenicity from the sinus membrane. The nine remaining studies reported on the local effect of rhBMPs. The majority of these nine studies reported enhanced new bone formation in the sinus membrane region. Conclusions: The sinus membrane contains pluripotent mesenchymal cells with the capacity to differentiate and participate in the process of new bone formation. However, the findings from the studies selected in this systematic review do not consistently support that the sinus membrane significantly contributes to new bone formation following maxillary sinus augmentation procedures.
- Open Access
- 1 March 2020
- Vol. 18 (2) , 103-113
Association of Vitamin D With Periodontal Disease: A Narrative Review
Purpose: To present a review of available literature on the association of vitamin D and periodontal disease. Materials and Methods: A thorough search of articles was carried out on the databases PUBMED and MEDLINE regarding vitamin D and periodontal disease. The selected literature included ...
- 1 March 2020
- Vol. 18 (2) , 103-113
Open AccessAssociation of Vitamin D With Periodontal Disease: A Narrative Review
Purpose: To present a review of available literature on the association of vitamin D and periodontal disease. Materials and Methods: A thorough search of articles was carried out on the databases PUBMED and MEDLINE regarding vitamin D and periodontal disease. The selected literature included ...
- Open Access
- 1 January 2020
- Published by Medicina Oral, S.L. in Medicina Oral Patología Oral y Cirugia Bucal
- Vol. 25 (4) , e474-e480
One-year implant survival following lateral window sinus augmentation using plasma rich in growth factors (PRGF): a retrospective study
Background: The aim of this study was to assess one-year implant survival after lateral window sinus augmentation using PRGF combined with various bone grafting materials. Material and Methods: This was a retrospective chart review and radiographic analysis of patients that had undergone lateral window sinus augmentation with PRGF and had dental implants placed at least 6 months post augmentation. All implants included were followed up for at least one year after placement. Demographic, sinus and implant related characteristics (residual ridge height, sinus membrane perforation, type of graft material, implant length and width and ISQ at placement) were analyzed. Results: A total of 31 patients with 39 sinus augmentations and 48 implants were included. The mean follow up was 22.8 +/- 9.9 months. Implant survival was 95.8%, with 2 implants overall failing. Among all the variables assessed, the only one found to be associated with an increased risk for implant failure was the use of xenograft as bone grafting material in the sinus. Conclusions: Within the limitations of this study, dental implants placed in maxillary sinuses grafted with PRGF in combination with bone grafting materials, exhibit high implant survival rates after at least one year follow up.
- 1 January 2020
- Published by Medicina Oral, S.L. in Medicina Oral Patología Oral y Cirugia Bucal
- Vol. 25 (4) , e474-e480
Open AccessOne-year implant survival following lateral window sinus augmentation using plasma rich in growth factors (PRGF): a retrospective study
Background: The aim of this study was to assess one-year implant survival after lateral window sinus augmentation using PRGF combined with various bone grafting materials. Material and Methods: This was a retrospective chart review and radiographic analysis of patients that had undergone lateral window sinus augmentation with PRGF and had dental implants placed at least 6 months post augmentation. All implants included were followed up for at least one year after placement. Demographic, sinus and implant related characteristics (residual ridge height, sinus membrane perforation, type of graft material, implant length and width and ISQ at placement) were analyzed. Results: A total of 31 patients with 39 sinus augmentations and 48 implants were included. The mean follow up was 22.8 +/- 9.9 months. Implant survival was 95.8%, with 2 implants overall failing. Among all the variables assessed, the only one found to be associated with an increased risk for implant failure was the use of xenograft as bone grafting material in the sinus. Conclusions: Within the limitations of this study, dental implants placed in maxillary sinuses grafted with PRGF in combination with bone grafting materials, exhibit high implant survival rates after at least one year follow up.
- 1 March 2019
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 47 (3) , 443-453
Plasma rich in growth factors (PRGF) in intraoral bone grafting procedures: A systematic review
- 1 March 2019
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 47 (3) , 443-453
Plasma rich in growth factors (PRGF) in intraoral bone grafting procedures: A systematic review
- 1 February 2019
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 48 (2) , 250-262
Effects of leukocyte–platelet-rich fibrin (L-PRF) in different intraoral bone grafting procedures: a systematic review
- 1 February 2019
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 48 (2) , 250-262
Effects of leukocyte–platelet-rich fibrin (L-PRF) in different intraoral bone grafting procedures: a systematic review
- 1 October 2017
- Published by American Academy of Implant Dentistry in Journal of Oral Implantology
- Vol. 43 (5) , 351-359
Complications Associated With the Use of Recombinant Human Bone Morphogenic Protein–2 in Ridge Augmentation: A Case Report
This case report aims to describe in detail a complication associated with resorption of regenerated bone following implant placement and ridge augmentation using recombinant human bone morphogenic protein–2 (rhBMP-2) in combination with allograft and xenograft. Bilateral maxillary sinus and ridge augmentation procedures were completed using rhBMP-2 combined with allograft and xenograft. Five months later, significant bone augmentation was achieved, which allowed for the placement of 4 implants. Upon stage 2 surgery, significant dehiscence was noted in all implants. Treatment steps to address this complication included implant removal, guided bone regeneration with xenograft only, and placement of new implants followed by soft-tissue grafting. At the time of publication, this patient is status 1½ years post case completion with maintenance of therapy outcomes. Off-label use of rhBMP-2 has gained significant acceptance in implant dentistry. However, there is limited evidence regarding the bone maturation process when rhBMP-2 is combined with other biomaterials. More research may be needed regarding the timing and process of bone healing in the presence of rhBMP-2, in an effort to avoid surgical complications.
- 1 October 2017
- Published by American Academy of Implant Dentistry in Journal of Oral Implantology
- Vol. 43 (5) , 351-359
Complications Associated With the Use of Recombinant Human Bone Morphogenic Protein–2 in Ridge Augmentation: A Case Report
This case report aims to describe in detail a complication associated with resorption of regenerated bone following implant placement and ridge augmentation using recombinant human bone morphogenic protein–2 (rhBMP-2) in combination with allograft and xenograft. Bilateral maxillary sinus and ridge augmentation procedures were completed using rhBMP-2 combined with allograft and xenograft. Five months later, significant bone augmentation was achieved, which allowed for the placement of 4 implants. Upon stage 2 surgery, significant dehiscence was noted in all implants. Treatment steps to address this complication included implant removal, guided bone regeneration with xenograft only, and placement of new implants followed by soft-tissue grafting. At the time of publication, this patient is status 1½ years post case completion with maintenance of therapy outcomes. Off-label use of rhBMP-2 has gained significant acceptance in implant dentistry. However, there is limited evidence regarding the bone maturation process when rhBMP-2 is combined with other biomaterials. More research may be needed regarding the timing and process of bone healing in the presence of rhBMP-2, in an effort to avoid surgical complications.